14 results
·
33ms
·
Sources: EU EUDAMED, US FDA
STAIRMASTER MODEL 6000 ERGOMETER
FDA 510(k)
FDA Class 2
·Physical Medicine
Malibu
FDA UDI
Seaspine Orthopedics Corporation·10889981080808·Tubular Sleeve
PICCOLO BASIC METABOLIC PANEL
FDA Adverse Event
Malfunction
·ABAXIS, INC.·Product code CGX·October 22, 2020
PICCOLO COMPREHENSIVE METABOLIC PANEL
FDA Adverse Event
Malfunction
·ABAXIS, INC.·Product code CGX·November 3, 2020
COM-PATCH
FDA 510(k)
FDA Class 2
·Neurology
7D Surgical System
FDA 510(k)
FDA Class 2
·Neurology
GII QA+ O/C CP-2 *EA
FDA Adverse Event
Malfunction
·DEPUY MITEK LLC US·Product code JDR·January 29, 2019
GII QA+ O/C CP-2 *EA
FDA Adverse Event
Malfunction
·DEPUY MITEK LLC US·Product code JDR·January 29, 2019
HS III PROXIMAL SEAL SYTEM 3.8MM
FDA Adverse Event
Malfunction
·MAQUET CARDIOVASCULAR, LLC·Product code DXC·May 13, 2014
PULSE GEN MODEL 103
FDA Adverse Event
Injury
·CYBERONICS INC·Product code LYJ·January 11, 2013
ACCU-CHEK ® COMPACT TEST DRUM
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS·Product code LFR·December 2, 2010
ORTHOPEDIC SALVAGE SYSTEM ARCOM LS TIBIAL BEARING 12MM
FDA Adverse Event
Injury
·ZIMMER BIOMET, INC.·Product code KRO·July 20, 2022
PM 1250 and PM 2250 ZENEX; PM1282 and PM2282 ZENEX MRI These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017
PM 1260 ASSURITY + These low voltage (LV) devices are implantable pacemaker pulse generators, intended to be permanently implanted in the body, that have a power supply and electronic circuits that produce a periodic electrical pulse to stimulate the heart. These devices are used as a substitute for the heart's intrinsic pacing system to correct both intermittent and continuous cardiac rhythm disorders.
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017